Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
FDA Accepts DCT Board’s Criteria For Approval Of New Drugs, Explains Plan for Early Action
This article is from
The Cancer Letter
archive.
Vol. 15 No. 07 | February 17, 1989
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Costs of Rosenberg Regimen Could Hinder cooperative Group Trials
January 3, 1986
TCL Archive
Chabner, FDA’s Temple continue disagreement Over Drug Approval
February 10, 1989
TCL Archive
ASTRO Announces Election Results, Staff Restructuring
September 17, 2010
TCL Archive
ACS Urges Practice Of Insurance Exclusion End Under Reform
February 5, 1993
TCL Archive
Drug Development Budget Cuts Force Early End To P388 Screening Contracts
January 9, 1987
TCL Archive
NCI’s New Policy On Costly Research
December 10, 1993